Literature DB >> 14641004

Sex hormones, inflammation and the metabolic syndrome: a population-based study.

David E Laaksonen1, Leo Niskanen, Kari Punnonen, Kristiina Nyyssönen, Tomi-Pekka Tuomainen, Riitta Salonen, Rainer Rauramaa, Jukka T Salonen.   

Abstract

OBJECTIVE: Mild hypoandrogenism in men is associated with features of the metabolic syndrome, but the association with the metabolic syndrome itself using an accepted definition has not been described.
DESIGN: Men with the metabolic syndrome were identified and testosterone and sex hormone-binding globulin (SHBG) levels were determined in a population-based cohort of 1896 non-diabetic middle-aged Finnish men.
RESULTS: Calculated free testosterone and SHBG were 11% and 18% lower (P<0.001) in men with the metabolic syndrome (n=345, World Health Organisation definition). After categorisation by tertiles and adjusting for age and body mass index, total and free testosterone and SHBG were inversely associated with concentrations of insulin, glucose, triglycerides, C-reactive protein (CRP) and CRP-adjusted ferritin and positively associated with high-density lipoprotein cholesterol. Men with free testosterone levels in the lowest third were 2.7 (95% confidence interval (CI) 2.0-3.7) times more likely to have the metabolic syndrome in age-adjusted analyses, and 1.7 (95% CI 1.2-2.4) times more likely even after further adjusting for body mass index. Exclusion of men with cardiovascular disease did not alter the association. The inverse association of SHBG with the metabolic syndrome was somewhat stronger.
CONCLUSIONS: Low testosterone and SHBG levels were strongly associated not only with components of the metabolic syndrome, but also with the metabolic syndrome itself, independently of body mass index. Furthermore, sex hormones were associated with inflammation and body iron stores. Even in the absence of late-stage consequences such as diabetes and cardiovascular disease, subtle derangements in sex hormones are present in the metabolic syndrome, and may contribute to its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14641004     DOI: 10.1530/eje.0.1490601

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  88 in total

1.  Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer.

Authors:  T Wethal; J Kjekshus; J Røislien; T Ueland; A K Andreassen; R Wergeland; P Aukrust; S D Fosså
Journal:  J Cancer Surviv       Date:  2007-03       Impact factor: 4.442

2.  Association between endogenous sex steroid hormones and inflammatory biomarkers in US men.

Authors:  K K Tsilidis; S Rohrmann; K A McGlynn; S J Nyante; D S Lopez; G Bradwin; M Feinleib; C E Joshu; N Kanarek; W G Nelson; E Selvin; E A Platz
Journal:  Andrology       Date:  2013-09-30       Impact factor: 3.842

3.  Follicle-stimulating hormone is associated with lipids in postmenopausal women.

Authors:  Corinna Serviente; Tomi-Pekka Tuomainen; Jyrki Virtanen; Sarah Witkowski; Leo Niskanen; Elizabeth Bertone-Johnson
Journal:  Menopause       Date:  2019-05       Impact factor: 2.953

Review 4.  Consensus statement on diagnosis and clinical management of Klinefelter syndrome.

Authors:  A F Radicioni; A Ferlin; G Balercia; D Pasquali; L Vignozzi; M Maggi; C Foresta; A Lenzi
Journal:  J Endocrinol Invest       Date:  2010-12       Impact factor: 4.256

Review 5.  Urological aspects of the metabolic syndrome.

Authors:  Jan Hammarsten; Ralph Peeker
Journal:  Nat Rev Urol       Date:  2011-08-02       Impact factor: 14.432

6.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

Review 7.  How much does obesity affect the male reproductive function?

Authors:  Giuseppe Bellastella; Davide Menafra; Giulia Puliani; Annamaria Colao; Silvia Savastano
Journal:  Int J Obes Suppl       Date:  2019-04-12

8.  The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.

Authors:  Farid Saad; Louis J Gooren
Journal:  J Obes       Date:  2010-08-10

9.  Sex-differentiated changes in C-reactive protein from ages 9 to 21: the contributions of BMI and physical/sexual maturation.

Authors:  Lilly Shanahan; William E Copeland; Carol M Worthman; Alaattin Erkanli; Adrian Angold; E Jane Costello
Journal:  Psychoneuroendocrinology       Date:  2013-05-25       Impact factor: 4.905

10.  Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania.

Authors:  Robin Haring; Henry Völzke; Stephan B Felix; Sabine Schipf; Marcus Dörr; Dieter Rosskopf; Matthias Nauck; Christof Schöfl; Henri Wallaschofski
Journal:  Diabetes       Date:  2009-07-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.